Introduction {#S1}
============

Traveling to a high altitude (HA) for sports, work, or recreational purposes is becoming popular but poses some physiological challenges to the cardiovascular system, leading to hypoxic pulmonary vasoconstriction, pulmonary vascular remodeling, and increases in pulmonary artery pressure (PAP) ([@B30]). In turn, elevated right ventricular (RV) afterload may predispose the RV to remodeling, hypertrophy, or even failure if HA hypoxia is sustained ([@B18]). Although it has been proposed that RV systolic function is well preserved and that its diastolic function is sometimes altered under acute HA hypoxia ([@B15]), exposure to HA at 8,000 m or acute hypoxia results in RV dilatation, an increased RV Tei index, and a decreased RV free wall longitudinal systolic strain ([@B9]; [@B17]). Moreover, significant decreases in tricuspid annular plane systolic excursion (TAPSE) and RV global longitudinal strain (RVGLS) have been found in healthy lowlanders after ascending to an HA of 5,050 m, suggesting that RV longitudinal systolic function is impaired ([@B24]). Therefore, although elevated PAP and HA hypoxia may potentially threaten RV performance, the effects of acute HA exposure on RV global or regional functions are controversial and inconclusive.

Evaluation of RV global or regional function at HA is of considerable importance because RV function (such as the Tei index) and elevated PAP are associated with impaired exercise capacity ([@B16]; [@B31]). Moreover, a previous report showed that subjects with previous HA pulmonary edema developed HA right-heart failure with severe tricuspid regurgitation (TR), dilatation of the RV chamber, and RV postsystolic shortening ([@B7]). The latter reflects RV dyssynchrony (RVD), which was calculated by the R--R interval-corrected standard deviation (SD) of the time-to-peak systolic strain for the four mid-basal RV segments (RVSD4) as detected by speckle-tracking echocardiography (STE). The presence of RVD usually suggests the variability of time differences in regional contraction through RV strain curves and is a more accurate estimate of RV function than the tissue Doppler method ([@B14]). In patients with pulmonary hypertension (PH), the presence of RVD is always associated with the symptomatology, functional state, exercise performance, and clinical outcomes ([@B14]; [@B20]). Recent evidence also showed that RVD occurred during hypoxia but not during exercise, suggesting the combined contributions of mechanical (RV afterload) and systemic (hypoxia) factors ([@B19]). Based on these reasons, we hypothesize that RVD is present under acute HA exposure and can be explained by HA hypoxia or increased RV afterload.

We therefore conducted the present study to determine whether acute HA exposure can induce regional heterogeneity of RV contraction or RVD and to explore the determinants and impacts.

Materials and Methods {#S2}
=====================

Participants and Study Procedures {#S2.SS1}
---------------------------------

Our research was approved by the Clinical Research Ethics Board of the Third Military Medical University (Army Medical University) (No. 2012015), was registered with the Center of Chinese Clinical Trial Registration (No. ChiCTR-RCS-12002232)^[1](#footnote1){ref-type="fn"}^, and complied with the Declaration of Helsinki. Informed consent was obtained from each participant in our study. Young Chinese male soldiers who permanently lived in lowland areas were enrolled in 2013 at sea level (SL) (\<500 m) in Chongqing and experienced a stair-type ascension to 4,100 m (Litang, Sichuan, China) from 400 m (Yanggongqiao, Chongqing, China) by bus within 7 days. Data collection was performed at SL and 5 ± 2 h after arrival at 4,100 m. Exclusion criteria were known cardiovascular and pulmonary diseases, any cardiovascular and pulmonary therapy, hematologic diseases, malignant tumors, liver or kidney dysfunction, history of HA-related diseases, or exposure to 2,500 m above SL in the past 6 months.

Echocardiographic Assessments {#S2.SS2}
-----------------------------

An echocardiographic study was performed using a CX50 ultrasound system (Philips Ultrasound System, Andover, MA, United States) equipped with a 2.5-MHz adult transducer by registered sonographers according to a standardized protocol ([@B11]). Standard two-dimensional (2D) and Doppler images were obtained in the left lateral decubitus position after 10 min of rest, stored for three consecutive beats, and then analyzed off-line on a digital image analysis system (QLAB 10.5, Philips Healthcare, Andover, MA, United States) by two independent investigators in a blind fashion.

The following parameters were analyzed or calculated: right atrial (RA) area, RV end-diastolic area (RVEDA), RV end-systolic area (RVESA), and RV fractional area change \[RV FAC, (RVEDA − RVESA)/RVEDA × 100\]. Pulsed Doppler RV inflow recordings were performed in the apical four-chamber view. The peak early (*E*) and late (*A*) diastolic flow velocities were measured, and the *E*/*A* ratio was calculated from the transtricuspid inflow. From a standard apical four-chamber window, tricuspid annular motion (TAM) was measured to evaluate RV longitudinal function according to guidelines from the American Society of Echocardiography ([@B21]).

Pulsed-wave Doppler recordings of pulmonary flow were performed from a modified basal short-axis view. Peak pulmonary artery velocity (PAV), the time of the pre-ejection period (PEP), pulmonary artery acceleration time (PAAT), pulmonary artery ejection time (PAET), and the presence of Notch were measured accordingly ([@B28]). The mean PAP (mPAP) was calculated from PAAT because it was present in all subjects; moreover, it is closely correlated with and substantially more feasible to measure than the maximal velocity of the TR jet (TRV) for the estimation of PAP: when PAAT was more than 120 ms, mPAP = 79 − (0.45 × AT), and when PAAT was less than 120 ms, mPAP = 90 − (0.62 × AT) ([@B29]). Systolic PAP (SPAP) was calculated by the modified Bernoulli equation: 4 × TRV^2^ + 5 mmHg (an estimated central venous pressure) ([@B21]).

With the use of color tissue Doppler imaging (TDI), the peak systolic velocity (tricuspid *s*'), early diastolic velocity (tricuspid *e*'), isovolumetric velocity (tricuspid IVV), and isovolumetric acceleration time (tricuspid IVAT) were measured at the lateral and septal tricuspid annular, and isovolumetric accelerated velocity (tricuspid IVA = IVV/IVAT) was calculated ([@B21]).

2D STE {#S2.SS3}
------

For STE analysis (QLAB 10.5), standard grayscale 2D images in the RV-focused apical four-chamber view were obtained (frame rate \>60 fps) and digitally stored for three consecutive cardiac cycles. Speckles were tracked frame by frame throughout the RV wall automatically, and segments that failed to track were manually adjusted by the researchers. Any segment with persistently inadequate tracking was excluded. The peak systolic myocardial strain measured by 2D STE was assessed in six RV segments including 2D strain (2DS) basal, middle, apical (the average of septum and free wall), and RVGLS. The time-to-peak systolic strain was measured as the time from onset of QRS complexes on ECG to maximum RV shortening by strain. The SD of the time-to-peak systolic strain was calculated as a parameter of mechanical dyssynchrony in a model with four mid-basal RV segments according to Bazett's formula; this measurement was called RVSD4 ([Figure 1A](#F1){ref-type="fig"}). Using the upper 95% limit of young healthy subjects at SL in our study, a cutoff value of 18.7 ms was defined as the criterion for RVD ([@B1]).

![Dyssynchrony evaluation by speckle-tracking analysis. 2D speckle-tracking imaging in the RV-focused view in a participant at SL **(A)** and a participant at HA **(B)**. Curves represent longitudinal strain curves, which were used to measure RVD and contractile function. RV, right ventricular; RVSD4, SD of the time-to-peak systolic strain for the four mid-basal RV segments.](fphys-11-00703-g001){#F1}

Reproducibility {#S2.SS4}
---------------

Observer reliability of RVSD4 was assessed in 20 randomly selected subjects: 10 from SL and 10 from HA. Interobserver variability was analyzed by two separate observers. Assessments of intraobserver variability were conducted in a random order at least 1 week apart. The Bland--Altman method was used to evaluate the intraobserver variability \[0.05 ± 2.74 (95% CI: −5.33 to + 5.43)\] and interobserver variability \[0.28 ± 3.26 (95% CI: −6.12 to + 6.68)\], which is considered acceptable for our study ([Figures 2A,B](#F2){ref-type="fig"}). The observer variability for the other echocardiographic parameters is presented in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}.

![Intraobserver and interobserver variability in RVSD4 measurements assessed by the Bland--Altman method. **(A)** Intraobserver variability. **(B)** Interobserver variability. Abbreviations as in [Figure 1](#F1){ref-type="fig"}.](fphys-11-00703-g002){#F2}

Covariates {#S2.SS5}
----------

Age, height, weight, Han ethnic status, and smoking status were obtained by using interviews or physical examinations. Body mass index (BMI) (kg/m^2^) was calculated by weight (kg)/height^2^ (m^2^). Heart rate (HR) was recorded from synchronous ECG when echocardiography was performed. Oxygen saturation (SaO~2~) was measured with warmed hands after signal stabilization by finger-pulse oximetry (Nonin ONYX OR9500, United States). Systolic and diastolic blood pressure (SBP and DBP) levels were taken in the supine position after 10 min of rest by an Omron HEM-6200 (Japan). Venous blood samples were collected after a 5-min rest, and routine blood tests were performed at SL and HA for the assessment of hemoglobin (Hb) concentration and hematocrit by a BC-3000 plus automated hematology corpuscle analyzer (Shenzhen, China).

Statistical Analysis {#S2.SS6}
--------------------

SPSS 22.0 software (IBM Corp., Armonk, NY, United States) was used to perform all statistical analyses. Continuous data were represented as the mean ± SD or medians (25th, 75th percentiles) based on their normality distribution according to the Kolmogorov--Smirnov test, and categorical data were represented as count and percentage. Differences between groups were tested by using an independent-sample *t*-test or the Mann--Whitney *U* test for unpaired variables. The chi-square test was used for categorical variables. A paired *t*-test or the Wilcoxon test was used for comparisons of continuous variables between SL and HA. The risk factors for the incidence of RVD at HA were analyzed by univariate logistic regression analysis followed by a stepwise algorithm (*P* \< 0.20 for entry and *P* \< 0.05 for stay). Relationships between continuous variables were measured by linear regression analysis. The figures in this study were made by using GraphPad Prism 6 software (GraphPad Prism Software Inc., La Jolla, CA, United States). All tests were two-sided, and *P*-values \<0.05 were considered statistically significant.

Results {#S3}
=======

Basic Characteristics and Physiological Parameters {#S3.SS1}
--------------------------------------------------

In this preliminary study, a total of 108 subjects aged 20 (19, 22) years with sufficient quality echocardiographic images were included. Representative pictures showed that RVSD4 was increased after acute HA exposure ([Figures 1A,B](#F1){ref-type="fig"}). Using the cutoff value of 18.7 ms as the criterion for RVD, the incidence of RVD at HA was 32.4%. There were no significant differences between the RVD− and RVD + groups in age, BMI, Han ethnicity, or smoking status. After acute HA exposure, HR, SBP, DBP, Hb concentration, and hematocrit were increased, but the values of SaO~2~ decreased in all RVD− and RVD + groups. However, subjects in the RVD + group had a lower SaO~2~ \[88.2 ± 2.7 vs. 89.0 ± 2.7%, *P* \< 0.05\] than those in the RVD- group after acute HA exposure ([Table 1](#T1){ref-type="table"} and [Figure 3A](#F3){ref-type="fig"}).

###### 

Physiologic parameters of the participants at sea level and at high altitude.

  **Variables**             **Total (*n* = 108)**   **RVD- (*n* = 73)**    **RVD + (*n* = 35)**                                                                                                         
  ------------------------- ----------------------- ---------------------- ---------------------- ---------------------- ---------------------- --------- ---------------------- ---------------------- ---------
  Age, years                20 (19, 22)                                    --                     21 (19, 23)                                   --        20 (19, 21)                                   --
  BMI, kg/m^2^              21.1 ± 1.8                                     --                     21.0 ± 1.7                                    --        21.2 ± 2.0                                    --
  Han ethnicity, *n* (%)    94 (87.0)                                      --                     63 (86.3)                                     --        31 (88.6)                                     --
  Smoking status, *n* (%)   69 (63.9)                                      --                     47 (64.4)                                     --        22 (62.9)                                     --
  HR, beats/min             66 (59, 74)             73 (64, 80)            \<0.001                64 (58, 72)            71 (64, 78)            \<0.001   70 (62, 77)            77 (64, 83)            0.003
  SaO~2~,%                  98 (97, 98)             89 (88, 91)            \<0.001                98 (97, 98)            90 (88, 91)            \<0.001   98 (97, 98)            88 (86, 91)\*          0.009
  SBP, mmHg                 112 (106, 118)          120 (112, 127)         \<0.001                111 (106, 118)         120 (113, 126)         0.035     116 (105, 124)         118 (112, 128)         0.006
  DBP, mmHg                 66 (62, 73)             78 (73, 84)            \<0.001                66 (63, 73)            78 (73, 84)            \<0.001   65 (60, 73)            78 (74, 85)            \<0.001
  Hb concentration, g/L     151.0 (142.0, 160.0)    167.0 (163.0, 177.5)   \<0.001                149.0 (141.5, 159.5)   169.0 (162.5, 178.5)   \<0.001   155.0 (144.0, 163.0)   167.0 (163.0, 173.0)   \<0.001
  Hematocrit (%)            42.5 (40.8, 45.3)       47.4 (44.7, 51.7)      \<0.001                42.1 (40.7, 45.0)      47.9 (44.8, 52.4)      \<0.001   43.6 (41.2, 46.1)      47.7 (44.7, 50.5)      \<0.001

Values are the median (25th to 75th quartiles) or the mean ± SD.\*

P

\< 0.05 compared with RVD-. RVD, right ventricular dyssynchrony; SL, sea level; HA, high altitude; BMI, body mass index; HR, heart rate; SaO

2

, oxygen saturation; SBP, systolic blood pressure; DBP, diastolic blood pressure; Hb, hemoglobin.

![Differences in the total, RVD+, and RVD− subgroups. Different levels of SaO~2~ **(A)**, SPAP **(B)**, IVA **(C)**, and RVGLS **(D)** in the total, RVD+, and RVD− subgroups. Values represent the mean ± standard error of the mean. \**P* \< 0.05, \*\**P* \< 0.01. Abbreviations are as in [Tables 1--3](#T1){ref-type="table"}.](fphys-11-00703-g003){#F3}

RV Function {#S3.SS2}
-----------

After acute HA exposure, RVSD4 was significantly increased in all subjects \[7.8 (2.9, 11.0) vs. 13.9 (6.7, 20.7) ms, *P* \< 0.001\] and in subjects with RVD \[7.2 (3.3, 9.8) vs. 22.7 (20.9, 30.9) ms, *P* \< 0.001\]. In all subjects, RA area, RV EDA, RV FAC, TAM, tricuspid *E*/*A* ratio, RVGLS, and 2DS (basal, middle, and apical) were decreased, whereas tricuspid IVV and IVA were increased following acute HA exposure. However, RVGLS \[−18.6 (−19.5, −16.6) vs. −19.6 (−21.3, −18.5)%, *P* \< 0.01\] and 2DS basal \[−18.6 (−19.8, −15.9) vs. −19.0 (−20.4, −17.9)%, *P* \< 0.05\] were even lower in subjects with RVD than in those without RVD. Moreover, increases in tricuspid IVV and IVA were found in subjects without RVD but not in those with RVD ([Table 2](#T2){ref-type="table"} and [Figures 3C,D](#F3){ref-type="fig"}).

###### 

Right ventricular parameters of the participants at sea level and at high altitude.

  **Variables**             **Total (*n* = 108)**   **RVD- (*n* = 73)**    **RVD + (*n* = 35)**                                                                                                                 
  ------------------------- ----------------------- ---------------------- ---------------------- ---------------------- ---------------------- ------------- ---------------------- -------------------------- -------------
  RA EDA, cm^2^             11.7 ± 2.1              11.2 ± 2.4             **0.008**              11.7 ± 2.3             11.0 ± 2.4             **0.023**     11.8 ± 1.8             11.5 ± 2.4                 0.457
  RV EDA, cm^2^             22.4 ± 3.9              21.1 ± 3.6             **0.001**              22.3 ± 3.7             20.8 ± 3.4             **0.001**     22.6 ± 4.3             21.7 ± 4.0                 0.218
  RV ESA, cm^2^             12.4 ± 2.2              12.4 ± 2.4             0.921                  12.4 ± 2.1             12.3 ± 2.3             0.665         12.4 ± 2.4             12.7 ± 2.7                 0.602
  RV FAC,%                  44.3 (42.0, 47.7)       41.8 (37.5, 44.2)      **\<0.001**            44.1 (42.2, 47.5)      41.6 (37.4, 44.3)      **\<0.001**   45.6 (41.8, 48.2)      41.8 (38.6, 44.2)          **\<0.001**
  TAM, mm                   20.6 (19.3, 23.0)       19.0 (17.3, 21.0)      **\<0.001**            20.4 (19.1, 23.0)      18.9 (17.4, 21.0)      **\<0.001**   21.0 (20.1, 23.2)      19.5 (16.8, 21.0)          **\<0.001**
  Tricuspid *E*/*A* ratio   1.99 (1.56, 2.39)       1.75 (1.41, 2.26)      **0.023**              2.02 (1.56, 2.48)      1.85 (1.47, 2.33)      0.068         1.98 (1.54, 2.17)      1.65 (1.36, 1.96)          0.238
  Tricuspid *s*', cm/s      7.9 ± 1.4               7.7 ± 1.3              0.279                  7.9±1.4                7.6±1.3                0.160         7.7±1.4                7.8±1.4                    0.813
  Tricuspid *e*', cm/s      7.3 ± 1.9               7.5 ± 2.2              0.233                  7.5±1.8                7.6±2.2                0.850         6.8±2.2                7.4±2.1                    0.247
  Tricuspid IVV, cm/s       3.4 (2.0, 4.6)          4.1 (2.9, 5.0)         **\<0.001**            3.7 (2.0, 4.5)         4.2 (3.0, 5.2)         **0.002**     2.8 (2.1, 4.7)         3.5 (2.5, 4.7)             0.133
  Tricuspid IVAT, ms        37 (33, 42)             37 (33, 43)            0.970                  38 (33, 43)            38 (33, 44)            0.725         36 (32, 40)            35 (30, 42)                0.632
  Tricuspid IVA, cm/s^2^    0.90 (0.58, 1.25)       1.05 (0.76, 1.35)      **0.001**              0.91 (0.56, 1.25)      1.08 (0.77, 1.43)      **0.004**     0.86 (0.60, 1.34)      0.95 (0.74, 1.28)          0.114
  RVGLS,%                   −20.5 (−22.0, −19.3)    −19.2 (−20.3, −17.7)   **\<0.001**            −20.5 (−21.9, −19.3)   −19.6 (−21.3, −18.5)   **0.008**     −20.1 (−22.1, −19.6)   −18.6 (−19.5, −16.6)\*\*   **\<0.001**
  2DS basal,%               −20.0 (−21.3, −18.6)    −18.2 (−20, −15.4)     **\<0.001**            −19.8 (−21.4, −18.6)   −19.0 (−20.4, −17.9)   **0.038**     −20.1 (−21.3, −18.6)   −18.6 (−19.8, −15.9)\*     **\<0.001**
  2DS middle,%              −21.3 (−22.6, −20.2)    −19.9 (−21.8, −18.3)   **\<0.001**            −21.5 (−22.9, −20.3)   −20.0 (−22.0, −18.3)   **\<0.001**   −21.0 (−22.0, −19.7)   −19.7 (−21.8, −18.7)       **0.035**
  2DS apical,%              --24.0 (−25.8, −23.0)   −23.0 (−24.9, −21.0)   **\<0.001**            −23.9 (−26.0, −22.9)   −23.4 (−25.2, −21.0)   **0.005**     −24.5 (−25.5, −23.4)   −22.5 (−24.7, −21.2)       **\<0.001**
  RVSD4, ms                 7.8 (2.9, 11.0)         13.9 (6.7, 20.7)       **\<0.001**            7.8 (2.7, 12.1)        9.9 (5.7, 14.0)        0.138         7.2 (3.3, 9.8)         22.7 (20.9, 30.9)\*\*      **\<0.001**

Values are the median (25th to 75th quartiles) or the mean ± SD. \*

P

\< 0.05, \*\*

P

\< 0.01 compared with RVD-. RA, right atrial; RV, right ventricular; EDA and ESA, end-diastolic and end-systolic areas; FAC, fractional area change; TAM, tricuspid annular motion;

E

, early diastolic velocity;

A

, late diastolic velocity;

s

', peak systolic velocity with tissue Doppler imaging;

e

', peak early diastolic velocity with tissue Doppler imaging; IVV, isovolumetric velocity; IVAT, isovolumetric acceleration time; IVA, isovolumetric acceleration; GLS, global longitudinal strain; 2DS, two-dimensional strain (average of septum and free wall); RVSD4, standard deviation in a model with four mid-basal RV segments. Other abbreviations are listed in

Table 1

. The bolded values mean

p

value \< 0.05.

Hemodynamics in Pulmonary Circulation {#S3.SS3}
-------------------------------------

In all subjects, the values of PAAT, PAET, PAAT/PAET, PAAT/PEP, and PAV were decreased, whereas PEP, mPAP, and the incidence of TR, TRV, and SPAP were increased following acute HA exposure. Additionally, 25 (23.1%) subjects with Notch were identified at HA. However, subjects with RVD showed higher TRV \[259 (231, 293) vs. 236 (218, 263) cm/s, *P* \< 0.05\] and higher SPAP \[30.7 (26.3, 39.4) vs. 27.2 (24.0, 32.7) mmHg, *P* \< 0.05\] than those without RVD at HA ([Table 3](#T3){ref-type="table"} and [Figure 3B](#F3){ref-type="fig"}).

###### 

Pulmonary hemodynamic parameters of the participants at sea level and at high altitude.

  **Variables**    **Total (*n* = 108)**   **RVD- (*n* = 73)**   **RVD + (*n* = 35)**                                                                                               
  ---------------- ----------------------- --------------------- ---------------------- ------------------- ------------------- --------- ------------------- --------------------- ---------
  PAAT, ms         132 ± 16                106 ± 19              \<0.001                132 ± 14            106 ± 18            \<0.001   131 ± 19            106 ± 19              \<0.001
  PAET, ms         354 ± 20                343 ± 28              \<0.001                357 ± 19            344 ± 28            \<0.001   348 ± 21            342 ± 27              0.222
  PEP, ms          65 (61, 74)             74 (65, 82)           \<0.001                65 (61, 74)         74 (64, 82)         \<0.001   64 (61, 74)         74 (67, 82)           0.001
  PAAT/PAET        0.37 ± 0.04             0.31 ± 0.05           \<0.001                0.37 ± 0.04         0.31 ± 0.05         \<0.001   0.38 ± 0.05         0.31 ± 0.05           \<0.001
  PAAT/PEP         2.00 (1.72, 2.31)       1.40 (1.20, 1.66)     \<0.001                1.99 (1.75, 2.31)   1.40 (1.20, 1.69)   \<0.001   2.06 (1.62, 2.28)   1.42 (1.20, 1.65)     \<0.001
  PAV, cm/s        108 (97, 121)           99 (90, 109)          \<0.001                105 (97, 121)       98 (90, 108)        \<0.001   115 (96, 124)       103 (94, 110)         0.010
  mPAP, mmHg       18.5 (14.6, 22.5)       26.3 (21.0, 32.6)     \<0.001                18.5 (15.4, 22.5)   24.9 (21.4, 32.3)   \<0.001   18.6 (14.0, 22.4)   28.1 (20.2, 32.6)     \<0.001
  Notch, *n* (%)   0 (0)                   25 (23.1)             N/A                    0 (0)               19 (26.0)           N/A       0 (0)               6 (17.1)              N/A
  TR, *n* (%)      72 (66.7)               86 (79.6)             0.021                  49 (67.1)           56 (76.7)           0.197     23 (65.7)           30 (85.7)             0.051
  TRV, cm/s        215 (191, 234)          239 (223, 278)        \<0.001                215 (187, 235)      236 (218, 263)      \<0.001   215 (191, 233)      259 (231, 293)\*      \<0.001
  SPAP, mmHg       23.5 (19.5, 26.8)       27.9 (24.9, 35.8)     \<0.001                23.5 (19.0, 27.1)   27.2 (24.0, 32.7)   \<0.001   23.4 (19.7, 26.8)   30.7 (26.3, 39.4)\*   \<0.001

Values are the median (25th to 75th quartiles) or the mean ± SD. \*

P

\< 0.05 compared with RVD-. PAAT, pulmonary artery acceleration time; PAET, pulmonary artery ejection time; PEP, pre-ejection period; PAV, peak pulmonary artery velocity; mPAP, mean pulmonary artery pressure; Notch, right ventricular outflow tract systolic Doppler flow velocity envelope; TRV, maximal velocity of the tricuspid regurgitation jet; SPAP, pulmonary systolic pressure. Other abbreviations are listed in

Table 1

.

Factors Associated With the Incidence of RVD at HA {#S3.SS4}
--------------------------------------------------

The results from univariate logistic regression showed that SaO~2~, RVGLS, and SPAP at HA were associated with the incidence of RVD at HA. Multivariate logistic regression identified two independent factors: SaO~2~ \[odds ratio (OR): 0.72, 95% CI: 0.56--0.92; *P* = 0.009\] and RVGLS (OR: 1.78, 95% CI: 1.31--2.41; *P* \< 0.001) ([Table 4](#T4){ref-type="table"}).

###### 

Logistic regression analysis of clinical factors for the incidence of RVD at high altitude.

  **Variables**             **Univariate**      **Stepwise multivariate**                       
  ------------------------- ------------------- --------------------------- ------------------- --------------
  Age                       0.99 (0.87, 1.13)   0.890                       Not selected        --
  Han ethnicity             0.81 (0.24, 2.80)   0.743                       Not selected        --
  BMI                       1.06 (0.85, 1.33)   0.611                       Not selected        --
  Smoking status            1.07 (0.46, 2.47)   0.877                       Not selected        --
  HR                        1.03 (0.99, 1.07)   **0.126**                   \-                  --
  SaO~2~                    0.82 (0.69, 0.98)   **0.025**                   0.72 (0.56, 0.92)   **0.009**
  SBP                       1.00 (0.96, 1.04)   0.944                       Not selected        --
  DBP                       1.02 (0.97, 1.06)   0.491                       Not selected        --
  Hb concentration          0.97 (0.94, 1.01)   **0.172**                   \-                  --
  Hematocrit                0.97 (0.90, 1.05)   0.463                       Not selected        --
  RA EDA                    1.08 (0.91, 1.29)   0.352                       Not selected        --
  RV FAC                    1.03 (0.93, 1.15)   0.551                       Not selected        --
  TAM                       0.97 (0.83, 1.13)   0.687                       Not selected        --
  Tricuspid *E*/*A* ratio   0.66 (0.31, 1.40)   0.280                       Not selected        --
  Tricuspid *s*'            1.11 (0.79, 1.54)   0.554                       Not selected        --
  Tricuspid *e*'            0.95 (0.78, 1.17)   0.649                       Not selected        --
  Tricuspid IVA             0.58 (0.20, 1.69)   0.317                       Not selected        --
  RVGLS                     1.32 (1.10, 1.58)   **0.002**                   1.78 (1.31, 2.41)   **\< 0.001**
  PAET                      1.00 (0.98, 1.01)   0.736                       Not selected        --
  PEP                       1.00 (0.96, 1.03)   0.858                       Not selected        --
  PAV                       1.02 (0.99, 1.05)   0.314                       Not selected        --
  mPAP                      1.01 (0.96, 1.06)   0.840                       Not selected        --
  SPAP                      1.07 (1.01, 1.14)   **0.022**                   --                  --

Values are the median (25th to 75th quartiles). OR, odds ratio; CI, confidence interval. Other abbreviations are listed in

Tables 1

--

3

. The bolded values mean

p

value \< 0.05.

Associations of mPAP With RVSD4 or RVGLS {#S3.SS5}
----------------------------------------

The linear regression analysis demonstrated that there was no significant correlation between the levels of mPAP and RVSD4 in all subjects at HA ([Figure 4A](#F4){ref-type="fig"}). However, mPAP was linearly associated with RVSD4 at HA in the presence of Notch (*r* = 0.403, *p* = 0.046) ([Figure 4B](#F4){ref-type="fig"}). Furthermore, RVSD4 was linearly associated with RVGLS at HA (*r* = 0.383, *p* \< 0.001) ([Figure 4C](#F4){ref-type="fig"}). Although there was no significant correlation between mPAP and RVGLS in all subjects at HA, mPAP was linearly associated with RVGLS at HA in subjects with RVD (*r* = 0.361, *p* = 0.028) ([Figures 4D,E](#F4){ref-type="fig"}).

![Linear relationships between mPAP and RVGLS or RVSD4 at HA. The linear relationship between mPAP and RVSD4 at HA in **(A)** all subjects and **(B)** subjects with Notch (red) and without Notch (black). The linear relationship between RVGLS and RVSD4 at HA in all subjects **(C)**. The linear relationships between mPAP and RVGLS at HA in **(D)** all subjects and **(E)** subjects with RVD (red) and without RVD (black). Abbreviations are as in [Figure 1](#F1){ref-type="fig"} and [Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}.](fphys-11-00703-g004){#F4}

Discussion {#S4}
==========

This is the first study to investigate RVD at HA in healthy subjects and shows that (1) the incidence of RVD after acute HA exposure at 4,100 m is approximately 32.4% in healthy young men; (2) SaO~2~ is an independent determinant of RVD at HA; (3) mPAP is linearly correlated with the magnitude of RVD in the presence of Notch; and (4) the presence and magnitude of RVD at HA result in reduced RVGLS and blunted tricuspid IVA.

RVD Measurements by STE Analysis {#S4.SS1}
--------------------------------

Cardiac magnetic resonance (CMR) is considered a good method for the quantitative assessment of the severity of electromechanical dyssynchrony ([@B32]). However, unlike portable echocardiography, CMR is not flexible and convenient for field studies at HA. In addition, the lower temporal resolution of CMR compared with echocardiography may affect the analysis of time-to-peak metrics ([@B22]). On the other hand, compared to the conventional TDI method, STE analysis can provide some advantages of angle independence and improved signal-to-noise ratio. Moreover, using the longitudinal strain analysis of STE is more accurate than using the wall velocities of TDI for evaluating intraventricular dyssynchrony ([@B21]). Additionally, considering the excessive variability in the apical segments for assessing the time-to-peak strain, even in healthy subjects, RVSD4 but not the SD of time-to-peak strain from six segments (RVSD6) was used to estimate RVD ([@B14]).

Determinants of HA Exposure-Induced RVD {#S4.SS2}
---------------------------------------

It has been demonstrated that RVD is mainly determined by the delayed contraction of the RV free wall at basal and mid-segments due to the non-uniformly distributed RV wall stress ([@B8]). RVD is always associated with elevated RV afterload, especially in patients with different kinds of PH. RVD has been shown to be attributed to an increase in RV afterload ([@B1]). HA exposure induces a decrease in SaO~2~ as well as an increase in PAP; however, our present results suggest that there are lower levels of SaO~2~ in subjects with RVD and a significant association between SaO~2~ and RVD incidence by univariate and multivariate logistic regression, indicating that HA hypoxia may play a critical role in HA exposure-induced RVD independent of RV overload. Not surprisingly, the absence of RV overload as a contributor to the incidence of RVD may be explained by the fact that the elevated PAP during the first few days at HA was moderate. Consistently, recent results also showed that acute hypoxia for several minutes, but not exercise, could induce regional inhomogeneity (or dyssynchrony) of RV contraction, although both acute hypoxia and exercise led to a comparable increase in RV afterload, suggesting that acute hypoxia was the main determinant of RVD but not RV afterload ([@B19]). Hypobaric hypoxia is the main characteristic of the HA environment but may result in the reduction in cardiac phosphocreatine (PCr)/ATP in healthy volunteers ([@B6]). In an animal model, hypoxia-induced RV dysfunction is attributed to the disturbance of fatty acid oxidation and mitochondrial respiration, which could not be explained by RV overload, suggesting a direct impairment of hypoxia on RV ([@B3]). Considering that the RV free wall is very thin and may be more sensitive to HA hypoxia, HA hypoxia-triggered RVD in the present study may be attributed to disturbed energy metabolism. However, the exact mechanisms involved need further investigation.

In our study, RV afterload (mPAP and SPAP) was not associated with the incidence of RVD. Consistently, a previous report showed that patients with borderline PH exhibited marked heterogeneity in RV contraction without any correlation with RV afterload ([@B10]). However, our results showed that SPAP was higher in subjects with RVD than in those without RVD and that SPAP was associated with the incidence of RVD by univariate logistic regression, which suggested a weak association between SPAP and RVD. The mPAP in our study was also not a contributor to the development of RVD; however, mPAP was linearly associated with RVSD4 in subjects with Notch formation, which was attributed to pulmonary artery reflected waves under an elevated RV afterload, according to recent guidelines from the American Society of Echocardiography ([@B2]), suggesting an underlying relationship between mPAP and RVD. Previous results showed that RV size was another contributing factor to RVD ([@B4]). In our study, RV size was not associated with the incidence of RVD, although the RA area and RVEDA had decreased after HA exposure due to hypovolemia, especially after several days of acclimatization, similar to our research setting ([@B25]). Similarly, the elevated afterload seemed to be an important cause of LV dyssynchrony in normal subjects with the absence of other confounding factors, such as ventricular size ([@B13]).

RV Function {#S4.SS3}
-----------

In our present study, the increases in Hb concentration and hematocrit suggested that the blood volume was significantly decreased, which may lead to the reduction in ventricular filling ([@B25]). Thus, the reduced RV preload due to hypovolemia resulted in a significant but slight decline in RV FAC, which is a load-dependent estimation of RV systolic function ([@B21]). Consistent with previous results, although the *P* value is 0.06, the comparable values of FAC with ours showed a trend toward a decline, which may be attributed to the limited sample size ([@B12]). Moreover, the TAM and RV strain also decreased after HA exposure, which was consistent with a previous study ([@B24]). Taken together, these results indicate that although parameters such as FAC and TAM were load dependent, the regional function was altered based on the decreased RV strain.

Although data from PAH patients showed that RVD was strongly correlated with impaired RV function and adverse RV remodeling ([@B5]), we did not find any additional changes in the decreased FAC and TAM in subjects with RVD. However, subjects with RVD showed lower values of RVGLS than subjects without RVD, which was mainly attributed to the decline in RV strain at basal segments, suggesting that regional RV function was more affected by RVD. Similarly, it has been demonstrated that the presence of RVD was associated with reduced RVGLS in children with PAH as evaluated by CMR ([@B22]). Furthermore, we also found a significant increase in tricuspid IVA in all subjects and RVD- subjects but not in RVD + subjects after HA exposure, which indicated that RV IVA was blunted by RVD. It has been suggested that IVA is an ideal method for evaluating acute changes in RV function in a preload- and afterload-independent manner ([@B27]). Furthermore, RV IVA has been considered a useful method for identifying early RV systolic alterations and predicting RV contractile dysfunction in the future ([@B26]). However, whether the blunted RV IVA in subjects with RVD after acute HA exposure persisted or was reversible remains to be investigated.

Study Limitations {#S4.SS4}
-----------------

There are some limitations in the present study. First, all the included subjects were young healthy men, and whether the present conclusion could extend to others is still unknown. Second, 2D STE is mainly based on plane selection and therefore may be inferior to 3D STE for evaluating RV function ([@B23]). Third, echocardiography instead of RV catheterization was used to evaluate the PAP because invasive procedures are unnecessary and unethical in healthy individuals despite right-heart catheterization being the gold standard.

Conclusion {#S5}
==========

For the first time, we demonstrated that acute HA exposure could induce RVD in healthy subjects, which may be mainly attributed to the decline in SaO~2~ as well as the increase of RV afterload; the incidence of RVD at HA was associated with reduced RV regional function and blunted myocardial acceleration. Our findings may provide novel insight into the understanding of RV adaptation to HA exposure. Further investigations are needed to clarify the clinical relevance of these findings.
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